THERAPEUTIC CLASS

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

---

Results of small-scale studies have suggested that stem-cell therapy is safe and effective in patients with
liver cirrhosis, but no adequately powered randomised controlled trials have been done. We assessed the safety and
efficacy of granulocyte colony-stimulating factor (G-CSF) and haemopoietic stem-cell infusions in patients with
liver cirrhosis.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

SNMC
Gastrointestinal & Hepatobiliary System
Lolindex

Specific Detail Info

Lancet Gastroenterol Hepatol 2018; 3: 25–36

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment